IL82862A0 - Therapeutic compositions comprising a cytokine - Google Patents

Therapeutic compositions comprising a cytokine

Info

Publication number
IL82862A0
IL82862A0 IL82862A IL8286287A IL82862A0 IL 82862 A0 IL82862 A0 IL 82862A0 IL 82862 A IL82862 A IL 82862A IL 8286287 A IL8286287 A IL 8286287A IL 82862 A0 IL82862 A0 IL 82862A0
Authority
IL
Israel
Prior art keywords
cytokine
therapeutic compositions
therapeutic
compositions
Prior art date
Application number
IL82862A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL82862A0 publication Critical patent/IL82862A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/191Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL82862A 1986-06-16 1987-06-14 Therapeutic compositions comprising a cytokine IL82862A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87473686A 1986-06-16 1986-06-16
US5393887A 1987-05-22 1987-05-22

Publications (1)

Publication Number Publication Date
IL82862A0 true IL82862A0 (en) 1987-12-20

Family

ID=26732412

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82862A IL82862A0 (en) 1986-06-16 1987-06-14 Therapeutic compositions comprising a cytokine

Country Status (8)

Country Link
EP (1) EP0250192A3 (xx)
JP (1) JPH07100662B2 (xx)
AU (1) AU598817B2 (xx)
DK (1) DK302887A (xx)
IL (1) IL82862A0 (xx)
NZ (1) NZ220686A (xx)
PH (1) PH26613A (xx)
PT (1) PT85076B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
DE3613166A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148311B1 (en) * 1983-12-26 1988-07-20 Asahi Kasei Kogyo Kabushiki Kaisha A novel physiologically active polypeptide
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
GR851626B (xx) * 1984-07-05 1985-11-26 Genentech Inc
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines

Also Published As

Publication number Publication date
DK302887D0 (da) 1987-06-15
DK302887A (da) 1987-12-17
EP0250192A2 (en) 1987-12-23
AU7422387A (en) 1987-12-17
PH26613A (en) 1992-08-19
AU598817B2 (en) 1990-07-05
NZ220686A (en) 1990-02-26
PT85076A (en) 1987-07-01
JPH07100662B2 (ja) 1995-11-01
JPS6354327A (ja) 1988-03-08
PT85076B (pt) 1990-07-31
EP0250192A3 (en) 1988-02-10

Similar Documents

Publication Publication Date Title
GB8426152D0 (en) Medicinal compositions
ZA881791B (en) Therapeutic compositions
GB8521275D0 (en) Therapeutic composition
GB8606468D0 (en) Therapeutic compositions
GB8630251D0 (en) Therapeutic composition
GB8707656D0 (en) Pain compositions
PH24227A (en) Sustained released pharmaceutical compositions
GB8508404D0 (en) Therapeutic compositions
IL82862A0 (en) Therapeutic compositions comprising a cytokine
GB8628475D0 (en) Medicaments
GB8708225D0 (en) Dosage form
GB8625326D0 (en) Medicaments
GB8611808D0 (en) Occlusal bite-check
GB8419245D0 (en) Medicinal compositions
GB8924207D0 (en) Formulations
ZA874324B (en) Therapeutic compositions
GB8616931D0 (en) Therapeutic compositions
IE891364L (en) Administering a cytokine
GB9008780D0 (en) Therapeutic compositions
GB8908847D0 (en) Therapeutic compositions
GB8710656D0 (en) Therapeutic composition
IE870463L (en) Interferon compositions
GB8606455D0 (en) Formulations
GB8606755D0 (en) Formulations
IE862216L (en) Pharmaceutical compositions comprising acylated¹phospholipids